Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
Open Access
- 1 September 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 3 (3) , 165-173
Abstract
Introduction Numerous testosterone (T) formulations are available, each with differing effects on serum parameters. Aim The aim of this study was to compare the long‐term effects of topical, injectable, and implantable pellet T formulations in hypogonadal men. Methods Retrospective review of hypogonadal men treated with a single T formulation was performed: 47 men on T gels, 57 on injectable T, and 74 on T pellets were identified. Total T (TT), calculated free T (FT), estradiol (E), hemoglobin (Hgb), hematocrit (Hct), prostate‐specific antigen (PSA), total cholesterol (Tchol), triglycerides (TG), low‐density lipoprotein (LDL), and high‐density lipoprotein (HDL) cholesterol were evaluated at baseline and every 3–6 months for 3 years. Serum parameters were compared using a mixed model linear regression for repeated measures. Main Outcome Measures Effects of topical, injectable, and pellet T formulations on serum hormone levels, Hgb, Hct, lipid parameters and PSA. Results Men in the injectable T group were younger (42.5 ± 12.3 years) than in the gel (54.1 ± 9.8 years) or pellet groups (53.8 ± 13.0 years), and baseline FT, Hgb, and Hct were higher in the injectable T group than in gel or pellet groups. Increases in TT and FT were observed throughout follow‐up in all groups. Increases in E were observed at in all T groups and throughout follow‐up in injectable and gel groups. No PSA increases were observed. Erythrocytosis (Hct > 50%) was more common with injectable T (66.7%) than with T gels (12.8%) or pellets (35.1%, P < 0.0001). Transient changes in cholesterol, TG, and LDL were observed, and no significant changes were seen in HDL for any group. Conclusions All T formulations increase serum T and FT. More significant increases in E occur with injectable T and T gels. Changes in Hgb and Hct are most significant with injectable T, and effects on lipids are variable and inconsistent. Selection of T formulations must account for individual patient preferences and the effects of each formulation. Pastuszak AW, Gomez LP, Scovell JM, Khera M, Lamb DJ, and Lipshultz LI. Comparison of the effects of testosterone gels, injections, and pellets on serum hormones, erythrocytosis, lipids, and prostate‐specific antigen. Sex Med 2015;3:165–173.Keywords
Funding Information
- Development Physician-Scientist Award (HD073917-01)
- National Institute of Child Health and Human Development
This publication has 43 references indexed in Scilit:
- Factors Influencing Patient Decisions to Initiate and Discontinue Subcutaneous Testosterone Pellets (Testopel) for Treatment of HypogonadismThe Journal of Sexual Medicine, 2013
- Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trialsBMC Medicine, 2013
- The 20-Year Public Health Impact and Direct Cost of Testosterone Deficiency in U.S. MenThe Journal of Sexual Medicine, 2013
- Pharmacokinetic Evaluation and Dosing of Subcutaneous Testosterone PelletsJournal of Andrology, 2012
- Testosterone Therapy in Men With Untreated Prostate CancerJournal of Urology, 2011
- Testosterone Suppresses Hepcidin in Men: A Potential Mechanism for Testosterone-Induced ErythrocytosisThe Journal of Clinical Endocrinology & Metabolism, 2010
- The Effects of Injected Testosterone Dose and Age on the Conversion of Testosterone to Estradiol and Dihydrotestosterone in Young and Older MenThe Journal of Clinical Endocrinology & Metabolism, 2010
- Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2010
- The benefits and risks of testosterone replacement therapy: a reviewTherapeutics and Clinical Risk Management, 2009
- Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly menAtherosclerosis, 1996